The cost of unfractionated and low-molecular weight heparin in the management of acute coronary syndromes

Canadian Journal of Hospital Pharmacy

Volumn 52, Issue 2, 1999, Pages 72-76

  Paradiso Hardy, Fran L ^a,b,c   Oh, Paul ^c  

^a Pharmacy Department   (Canada)

^b SUNNYBROOK RESEARCH INSTITUTE   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

Author keywords

Acute coronary syndromes; Heparin; Intravenous therapy; Low molecular weight heparin; Time motion

Indexed keywords

DALTEPARIN; LOW MOLECULAR WEIGHT HEPARIN;

ACUTE HEART INFARCTION; ARTICLE; COST EFFECTIVENESS ANALYSIS; DRUG COST; HEPARINIZATION; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LABORATORY; NURSING; PATIENT MONITORING; SUBCUTANEOUS DRUG ADMINISTRATION; TIME; TREATMENT OUTCOME; UNSTABLE ANGINA PECTORIS;

EID: 0032770120     PISSN: 00084123     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (9)

1. Hirsh J, Fuster V. Guide to anticoagulant therapy. Circulation. 1994;89:1449-68.
2. Cohen M, Deniers C, Gurfinkel E, et al. A comparison of low-molecular-weight-heparin with unfractionated heparin for unstable coronary artery disease. N Engl J Med. 1997;337:447-52.
3. Gurfinkel E, Manos E, Mejail R, et al. Low molecular weight heparin versus regular heparin or aspirin in the treatment of unstable angina and silent ischemia. J Am Coll Cardiol. 1995;26:313-8.
4. Klein W, Buchwald A, Hillis S, al. e, for the FRIC Investigators. Comparison of low-molecular-weight heparin with unfractionated heparin acutely and with placebo for 6 weeks in the management of unstable coronary artery disease. Fragmin in Unstable Coronary Artery Disease Study (FRIC). Circulation. 1997;96:61-8.
5. Paradiso-Hardy F, Cheung B, Geerts W. Evaluation of an intravenous heparin nomogram in a coronary care unit. Can J Cardiol. 1996;12:802-8.
6. Mark D, Cowper P, Berkowitz S, et al. Economic assessment of low-molecular-weight heparin (enoxaparin) versus unfractionated heparin in acute coronary syndrome patients. Results from the ESSENCE randomized trial. Circulation. 1998;97:1702-7.
7. Lensing A, Prins M, Davidson B, Hirsh J. Treatment of deep venous thrombosis with low-molecular-weight heparins. A metaanalysis. Arch Intern Med. 1995;155:601-7.
8. French R. Fragmin shows encouraging results in unstable angina. British Journal of Cardiology. 1997;4(1):12-13.
9. Antman E, and the Thrombolysis in Myocardial Infarction (TIMI) 11B Trial Investigators. TIMI 11B. Enoxaparin versus unfractionated heparin for unstable angina for non-Q-wave myocardial infarction: A double-blind, placebo-controlled, parallel-group, multicenter trial. Rationale, study design, and methods. Am Heart J. 1998;135(suppl):353-60.